文献速递围术期管理与 ERAS胃肠外科急腹症与外科感染

术后多模式镇痛:非阿片类药物与技术综述

Postoperative Multimodal Analgesia Pain Management With Nonopioid Analgesics and Techniques: A Review.
PubMed 文献 · JAMA Surg · 2017-01-01

本文综述了ERAS路径中减少阿片类药物的多模式镇痛方案。区域阻滞、对乙酰氨基酚、非甾体抗炎药、加巴喷丁类、曲马多、利多卡因及NMDA受体拮抗剂均为有效辅助。一项27项RCT的荟萃分析显示酮咯酸组与对照组术后出血无差异。结直肠ERAS路径采用多模式镇痛后多数患者住院期间阿片用量减少。

要点

  • 多模式镇痛证据强,应常规用于ERAS及非ERAS患者以减少阿片消耗。
  • 非甾体抗炎药不增加术后出血,荟萃分析支持安全使用。
  • 结直肠ERAS路径采用多模式镇痛后多数患者住院期间阿片用量减少。

核心结论

  • 多模式镇痛易于获得且证据充分,外科医生应对ERAS及非ERAS患者使用该有效方案以减少阿片类药物消耗。

研究设计与样本

  • 综述,汇总区域阻滞、对乙酰氨基酚、非甾体抗炎药、加巴喷丁类、曲马多、利多卡因及NMDA受体拮抗剂等非阿片类镇痛证据。

主要发现

  • 区域镇痛、对乙酰氨基酚、非甾体抗炎药、加巴喷丁类、曲马多、利多卡因及NMDA受体拮抗剂均为阿片类镇痛的有效辅助。
  • 非甾体抗炎药不增加术后出血。
  • 27项RCT荟萃分析:酮咯酸组术后出血33/1304例(2.5%),对照组21/1010例(2.1%),OR 1.1(95%CI 0.61-2.06,P=.72)。
  • 结直肠ERAS路径采用多模式镇痛后,多数患者住院期间阿片用量减少,许多患者出院后无需阿片,但约50%患者住院期间接受过某种阿片。

关键数值与推荐

  • 酮咯酸与对照组术后出血比较:OR 1.1(95%CI 0.61-2.06,P=.72),差异无统计学意义。

临床怎么用

  • 对ERAS及非ERAS患者常规采用多模式镇痛,联合区域阻滞、对乙酰氨基酚、非甾体抗炎药等非阿片类药物与技术以减少阿片消耗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Amid the current opioid epidemic in the United States, the enhanced recovery after surgery pathway (ERAS) has emerged as one of the best strategies to improve the value and quality of surgical care and has been increasingly adopted for a broad range of complex surgical procedures. The goal of this article was to outline important components of opioid-sparing analgesic regimens. OBSERVATIONS: Regional analgesia, acetaminophen, nonsteroidal anti-inflammatory agents, gabapentinoids, tramadol, lidocaine, and/or the N-methyl-d-aspartate class of glutamate receptor antagonists have been shown to be effective adjuncts to narcotic analgesia. Nonsteroidal anti-inflammatory agents are not associated with an increase in postoperative bleeding. A meta-analysis of 27 randomized clinical trials found no difference in postoperative bleeding between the groups taking ketorolac tromethamine (33 of 1304 patients [2.5%]) and the control groups (21 of 1010 [2.1%]) (odds ratio [OR], 1.1; 95% CI, 0.61-2.06; P = .72). After adoption of the multimodal analgesia approach for a colorectal ERAS pathway, most patients used less opioids while in the hospital and many did not need opioids after hospital discharge, although approximately 50% of patients received some opioid during their stay. CONCLUSIONS AND RELEVANCE: Multimodal analgesia is readily available and the evidence is strong to support its efficacy. Surgeons should use this effective approach for patients both using and not using the ERAS pathway to reduce opioid consumption.

来源:JAMA Surg,查看原文。版权归原作者所有。

引用

  1. Wick EC, Grant MC, Wu CL, et al. Postoperative Multimodal Analgesia Pain Management With Nonopioid Analgesics and Techniques: A Review. JAMA Surg. 2017. PMID: 28564673. doi:10.1001/jamasurg.2017.0898

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。